Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1656 |
Vandetanib
ZD6474,凡德他尼 |
Apoptosis; EGFR; VEGFR; Autophagy | Angiogenesis; Apoptosis; Autophagy; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Vandetanib (ZD6474) 是一种具有口服活性的VEGFR2/KDR 酪氨酸激酶抑制剂,IC50值为40 nM。它也抑制VEGFR3/FLT4和EGFR/HER1,IC50值分别为110和500 nM。 | |||
T64176 |
Vandetanib trifluoroacetate
|
||
Vandetanib trifluoroacetate (D6474 trifluoroacetate) 是一种口服具有活力的、有效的 VEGFR2/KDR 酪氨酸激酶抑制剂,其 IC50 值为 40 nM。Vandetanib trifluoroacetate 对 VEGFR3/FLT4 和 EGFR/HER1 也表现出抑制作用,他们的 IC50 值分别为 110 nM、500 nM。 | |||
T1656L |
Vandetanib Fumarate
HSDB 8198,Zactima,Caprelsa,ZD 6474,Vandetanib |
||
Vandetanib Fumarate is an orally available tyrosine kinase inhibitor. Vandetanib Fumarate works by blocking RET (REarranged during Transfection), vascular endothelial growth factor receptor (VEGFR-2, VEGFR-3), and epidermal growth factor receptor and to a | |||
T21641 |
Vandetanib hydrochloride
|
||
Vandetanib hydrochloride (D6474 hydrochloride) 是一种有效的,口服的VEGFR2/KDR 酪氨酸激酶抑制剂 (IC50=40 nM)。Vandetanib hydrochloride 对于VEGFR3/FLT4(IC50=110 nM) 和EGFR/HER1(IC50=500 nM)也有抑制作用。 |